Reach out to the Acquis team
Coupa’s January 2026 Release (R44) isn’t chasing headlines. While the platform continues to move toward its longer-term vision of autonomous spend management, this release focuses on something more immediate: reducing the everyday friction that slows finance and procurement teams down.
Read More
AI agents that can read, write, and act across systems are making traditional integration obsolete. The question many firms are now asking: Should we maintain 20 specialized systems when AI agents can deliver comparable capabilities using 5-7 core platforms? The economics increasingly suggest the answer is no.
Read More
At the end of 2025, we were closely monitoring three trends we believed would shape the next phase of biopharma’s operating model changes in 2026: data pipelines, the role of AI in due diligence, and the next-generation value chain. The J.P. Morgan Healthcare Conference offered the first opportunity to pressure-test those assumptions.
Read More
Coupa’s January 2026 Release (R44) isn’t chasing headlines. While the platform continues to move toward its longer-term vision of autonomous spend management, this release focuses on something more immediate: reducing the everyday friction that slows finance and procurement teams down.
Read More
AI agents that can read, write, and act across systems are making traditional integration obsolete. The question many firms are now asking: Should we maintain 20 specialized systems when AI agents can deliver comparable capabilities using 5-7 core platforms? The economics increasingly suggest the answer is no.
Read More
At the end of 2025, we were closely monitoring three trends we believed would shape the next phase of biopharma’s operating model changes in 2026: data pipelines, the role of AI in due diligence, and the next-generation value chain. The J.P. Morgan Healthcare Conference offered the first opportunity to pressure-test those assumptions.
Read More
